Mariano Ferraresso

Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients

Mariano Ferraresso, Amedea Silvia Tirelli, Luciana Ghio et al. · Pediatric Transplantation · 2007 · 68 citations

Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.

Mariano Ferraresso, Ling Tian, Rafik Ghobrial et al. · The Journal of Immunology · 1994 · 59 citations · Full text

Noncytotoxic Antibodies, Cell Therapy, Immunology +21

Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation

Stefano Turolo, Amedea Silvia Tirelli, Mariano Ferraresso et al. · Pharmacological Reports · 2010 · 52 citations

Italian Teenagers, Transplantation, Kidney Transplant +7

COVID-19 and kidney transplantation: an Italian Survey and Consensus

Fabio Vistoli, Lucrezia Furian, Umberto Maggiore et al. · Journal of Nephrology · 2020 · 52 citations · Full text

Transplantation, Kidney Transplant, Medicine +9

Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.

Richard J. Knight, Mariano Ferraresso, Federica Serino et al. · PubMed · 1993 · 49 citations

Kidney Transplant, Kidney Transplantation, Immunosuppressive Therapy +10